-
Tytuł:
-
Technologies for Medication Adherence Monitoring and Technology Assessment Criteria: Narrative Review.
-
Autorzy:
-
Mason M; School of Nursing, University of Michigan, Ann Arbor, MI, United States.
Cho Y; School of Nursing, University of Michigan, Ann Arbor, MI, United States.
Rayo J; School of Nursing, University of Michigan, Ann Arbor, MI, United States.
Gong Y; School of Biomedical Informatics, University of Texas Health Science Center at Houston, Houston, TX, United States.
Harris M; School of Nursing, University of Michigan, Ann Arbor, MI, United States.
Jiang Y; School of Nursing, University of Michigan, Ann Arbor, MI, United States.
-
Źródło:
-
JMIR mHealth and uHealth [JMIR Mhealth Uhealth] 2022 Mar 10; Vol. 10 (3), pp. e35157. Date of Electronic Publication: 2022 Mar 10.
-
Typ publikacji:
-
Journal Article; Research Support, U.S. Gov't, P.H.S.; Review
-
Język:
-
English
-
Imprint Name(s):
-
Original Publication: Toronto: JMIR Publications Inc., [2013]-
-
MeSH Terms:
-
Technology Assessment, Biomedical*
Telemedicine*/methods
Humans ; Medication Adherence ; Technology
-
References:
-
Ther Adv Psychopharmacol. 2015 Apr;5(2):76-87. (PMID: 26240747)
Lancet Digit Health. 2019 Jun;1(2):e52-e54. (PMID: 33323229)
Technol Health Care. 2013;21(5):455-67. (PMID: 24029048)
Patient Prefer Adherence. 2020 Mar 20;14:625-634. (PMID: 32256053)
J Gen Med (Dover). 2017;1(1):. (PMID: 30345429)
Glob Health Sci Pract. 2016 Jun 27;4(2):211-21. (PMID: 27353615)
J Pharm Technol. 2017 Aug;33(4):137-139. (PMID: 34860983)
PLoS One. 2020 Apr 29;15(4):e0232337. (PMID: 32348351)
BMC Med Inform Decis Mak. 2020 Jun 10;20(1):105. (PMID: 32522263)
JMIR Form Res. 2019 Jun 25;3(2):e13558. (PMID: 31237568)
JMIR Ment Health. 2019 Mar 12;6(3):e12493. (PMID: 30860493)
JMIR Hum Factors. 2018 Nov 26;5(4):e10128. (PMID: 30478020)
AIDS Res Treat. 2020 May 27;2020:1098109. (PMID: 32566285)
J Med Internet Res. 2013 Jan 08;15(1):e6. (PMID: 23305649)
J Med Internet Res. 2017 Jan 13;19(1):e19. (PMID: 28087496)
PLoS One. 2018 Feb 5;13(2):e0190031. (PMID: 29401500)
Trials. 2017 Jul 4;18(1):286. (PMID: 28673323)
Curr HIV/AIDS Rep. 2015 Dec;12(4):523-31. (PMID: 26439917)
Lung India. 2019 Mar-Apr;36(2):108-111. (PMID: 30829243)
J Med Syst. 2011 Jun;35(3):377-89. (PMID: 20703552)
AIDS. 2013 Aug 24;27(13):2166-8. (PMID: 23751260)
Sensors (Basel). 2010;10(3):1652-60. (PMID: 22294891)
Transplantation. 2013 Aug 15;96(3):245-50. (PMID: 23823651)
Stud Health Technol Inform. 2017;235:28-32. (PMID: 28423749)
Disabil Rehabil Assist Technol. 2019 Nov;14(8):776-787. (PMID: 30451543)
JAMIA Open. 2021 Jun 18;4(2):ooab037. (PMID: 34159299)
AIDS Behav. 2019 Dec;23(12):3294-3305. (PMID: 30741397)
AIDS Care. 2019 Jun;31(6):761-766. (PMID: 30606037)
Eur Respir J. 2018 Nov 1;52(5):. (PMID: 30166325)
Ther Deliv. 2014 Jun;5(6):611-3. (PMID: 25090273)
Pilot Feasibility Stud. 2017 Feb 1;3:5. (PMID: 28168041)
ERJ Open Res. 2020 Apr 06;6(1):. (PMID: 32280670)
Curr HIV/AIDS Rep. 2018 Oct;15(5):388-396. (PMID: 30232578)
J Med Toxicol. 2015 Dec;11(4):439-44. (PMID: 26245878)
J Nephrol. 2016 Oct;29(5):627-36. (PMID: 26885659)
AIDS. 2017 Jan 2;31(1):169-171. (PMID: 27835622)
Clin Infect Dis. 2020 Dec 3;71(9):e513-e516. (PMID: 32221550)
West J Nurs Res. 2015 Jan;37(1):28-49. (PMID: 24577868)
Transl Behav Med. 2021 Feb 11;11(1):104-113. (PMID: 31580451)
Sensors (Basel). 2010;10(3):1535-52. (PMID: 22294885)
J Oncol Pharm Pract. 2014 Aug;20(4):249-56. (PMID: 24022406)
AIDS Res Treat. 2013;2013:957862. (PMID: 23956851)
PLoS One. 2013;8(1):e53373. (PMID: 23308203)
J Pediatr Hematol Oncol. 2021 Jan;43(1):e19-e25. (PMID: 33235145)
HIV Clin Trials. 2012 Sep-Oct;13(5):271-7. (PMID: 23134627)
Annu Int Conf IEEE Eng Med Biol Soc. 2012;2012:272-5. (PMID: 23365883)
Digit Health. 2016 Aug 03;2:2055207616663069. (PMID: 29942564)
J Clin Tuberc Other Mycobact Dis. 2019 Aug 29;17:100119. (PMID: 31788561)
J Med Syst. 2020 Feb 28;44(4):76. (PMID: 32112271)
Clin Transplant. 2021 May;35(5):e14278. (PMID: 33682207)
Annu Int Conf IEEE Eng Med Biol Soc. 2010;2010:3768-71. (PMID: 21096873)
Headache. 2016 Jul;56(7):1137-46. (PMID: 27167502)
Trials. 2019 Jul 12;20(1):426. (PMID: 31300028)
JMIR Mhealth Uhealth. 2018 May 17;6(5):e122. (PMID: 29773527)
Int J Med Inform. 2019 Nov;131:103949. (PMID: 31561192)
PLoS One. 2020 Jul 7;15(7):e0235572. (PMID: 32634140)
AIDS. 2016 Apr 24;30(7):1121-9. (PMID: 26785125)
PLoS One. 2019 Jul 22;14(7):e0219891. (PMID: 31329610)
Res Social Adm Pharm. 2016 Sep-Oct;12(5):794-800. (PMID: 26616159)
AIDS Behav. 2010 Dec;14(6):1294-301. (PMID: 20532605)
Annu Int Conf IEEE Eng Med Biol Soc. 2014;2014:4168-71. (PMID: 25570910)
IEEE Trans Biomed Eng. 2015 Jan;62(1):99-109. (PMID: 25069107)
Int J Environ Res Public Health. 2017 Sep 25;14(10):. (PMID: 28946683)
AIDS Behav. 2013 Nov;17(9):3101-7. (PMID: 23842718)
Annu Int Conf IEEE Eng Med Biol Soc. 2011;2011:5311-4. (PMID: 22255537)
Trials. 2017 Oct 16;18(1):480. (PMID: 29037222)
PLoS Med. 2019 Oct 4;16(10):e1002891. (PMID: 31584944)
AIDS Behav. 2010 Dec;14(6):1340-6. (PMID: 20809380)
BMJ Open. 2019 May 9;9(5):e028073. (PMID: 31076475)
Innov Clin Neurosci. 2016 Oct 01;13(9-10):12-19. (PMID: 27974996)
Math Biosci Eng. 2021 Jan 28;18(2):1513-1528. (PMID: 33757196)
Appl Clin Inform. 2013 Jan 30;4(1):37-52. (PMID: 23650486)
Clin Ther. 2017 May;39(5):1054-1061. (PMID: 28433400)
Proc Annu Hawaii Int Conf Syst Sci. 2016 Jan;2016:3416-3423. (PMID: 27182206)
Am J Health Syst Pharm. 2012 May 15;69(10):872-9. (PMID: 22555083)
Technol Health Care. 2012;20(6):511-20. (PMID: 23187016)
Int J Environ Res Public Health. 2019 Jan 31;16(3):. (PMID: 30709029)
BMC Med Ethics. 2020 Jan 8;21(1):3. (PMID: 31914995)
PLoS One. 2015 Jul 27;10(7):e0134275. (PMID: 26214848)
BMJ Glob Health. 2018 Oct 11;3(5):e001018. (PMID: 30364330)
Can Pharm J (Ott). 2021 Jul 30;154(5):312-323. (PMID: 34484481)
Patient Prefer Adherence. 2016 Oct 28;10:2171-2179. (PMID: 27822018)
J Clin Psychiatry. 2016 Sep;77(9):e1095-e1100. (PMID: 27379966)
J Med Internet Res. 2013 Jul 17;15(7):e141. (PMID: 23864345)
Curr Opin HIV AIDS. 2017 Sep;12(5):467-474. (PMID: 28590335)
AIDS Behav. 2014 May;18(5):833-40. (PMID: 24643314)
Addict Sci Clin Pract. 2018 Sep 24;13(1):21. (PMID: 30249279)
Transl Behav Med. 2015 Sep;5(3):285-93. (PMID: 26327934)
Transl Behav Med. 2015 Dec;5(4):470-82. (PMID: 26622919)
AMA J Ethics. 2019 Apr 1;21(4):E332-336. (PMID: 31012420)
Front Pharmacol. 2013 Mar 13;4:26. (PMID: 23493650)
Trials. 2020 May 5;21(1):383. (PMID: 32370774)
CMAJ. 2018 Oct 9;190(40):E1209-E1210. (PMID: 30998499)
Ci Ji Yi Xue Za Zhi. 2019 Apr-Jun;31(2):73-80. (PMID: 31007485)
BMC Public Health. 2011 Feb 09;11:92. (PMID: 21306643)
Med Care. 2019 Feb;57(2):e9-e14. (PMID: 30045159)
JMIR Mhealth Uhealth. 2017 Feb 21;5(2):e18. (PMID: 28223265)
-
Grant Information:
-
R01 HS022895 United States HS AHRQ HHS; R01 HS027846 United States HS AHRQ HHS
-
Contributed Indexing:
-
Keywords: medication adherence; remote sensing technology; technology assessment; telemedicine
-
Entry Date(s):
-
Date Created: 20220310 Date Completed: 20220316 Latest Revision: 20220716
-
Update Code:
-
20240104
-
PubMed Central ID:
-
PMC8949687
-
DOI:
-
10.2196/35157
-
PMID:
-
35266873
-
Background: Accurate measurement and monitoring of patient medication adherence is a global challenge because of the absence of gold standard methods for adherence measurement. Recent attention has been directed toward the adoption of technologies for medication adherence monitoring, as they provide the opportunity for continuous tracking of individual medication adherence behavior. However, current medication adherence monitoring technologies vary according to their technical features and data capture methods, leading to differences in their respective advantages and limitations. Overall, appropriate criteria to guide the assessment of medication adherence monitoring technologies for optimal adoption and use are lacking.
Objective: This study aims to provide a narrative review of current medication adherence monitoring technologies and propose a set of technology assessment criteria to support technology development and adoption.
Methods: A literature search was conducted on PubMed, Scopus, CINAHL, and ProQuest Technology Collection (2010-present) using the combination of keywords medication adherence, measurement technology, and monitoring technology. The selection focused on studies related to medication adherence monitoring technology and its development and use. The technological features, data capture methods, and potential advantages and limitations of the identified technology applications were extracted. Methods for using data for adherence monitoring were also identified. Common recurring elements were synthesized as potential technology assessment criteria.
Results: Of the 3865 articles retrieved, 98 (2.54%) were included in the final review, which reported a variety of technology applications for monitoring medication adherence, including electronic pill bottles or boxes, ingestible sensors, electronic medication management systems, blister pack technology, patient self-report technology, video-based technology, and motion sensor technology. Technical features varied by technology type, with common expectations for using these technologies to accurately monitor medication adherence and increase adoption in patients' daily lives owing to their unobtrusiveness and convenience of use. Most technologies were able to provide real-time monitoring of medication-taking behaviors but relied on proxy measures of medication adherence. Successful implementation of these technologies in clinical settings has rarely been reported. In all, 28 technology assessment criteria were identified and organized into the following five categories: development information, technology features, adherence to data collection and management, feasibility and implementation, and acceptability and usability.
Conclusions: This narrative review summarizes the technical features, data capture methods, and various advantages and limitations of medication adherence monitoring technology reported in the literature and the proposed criteria for assessing medication adherence monitoring technologies. This collection of assessment criteria can be a useful tool to guide the development and selection of relevant technologies, facilitating the optimal adoption and effective use of technology to improve medication adherence outcomes. Future studies are needed to further validate the medication adherence monitoring technology assessment criteria and construct an appropriate technology assessment framework.
(©Madilyn Mason, Youmin Cho, Jessica Rayo, Yang Gong, Marcelline Harris, Yun Jiang. Originally published in JMIR mHealth and uHealth (https://mhealth.jmir.org), 10.03.2022.)